5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Amanta Healthcare Ltd.

•
amanta.co.inBSE: 544502NSE: AMANTA
Market Cap₹ 756 Cr.
Current Price
High / Low₹ 206 / 92
Stock P/E51.5
Book Value₹ 58
Price to Book3.37
Dividend Yield0.00 %
ROCE15.2 %
ROE12.9 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 12.25x)
  • Institutional investors have been accumulating - FII+DII up 13.3pp
  • Company generates healthy free cash flow

CONS

  • Company has a high debt-to-equity of 2.02x
  • Promoter holding has decreased over last 2 years: -28.5pp
  • Recent results are weak - TTM profit is down 14.9% versus prior year
  • Company has a low return on equity of 5.1% over last 3 years
  • Interest coverage is weak at 1.5x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1899.0037.67455633.710.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9100.0082.59241576.410.33902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4850.0084.58184478.410.78566.003.284921.0057.3219.2733.81
4.CIPLA1385.0033.19111888.390.94785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1121.0024.78111820.180.09990.20-34.908017.0023.9721.3924.54
6.LAURUSLABS1840.0090.9399417.450.11362.07123.942026.3129.1018.2031.50
7.LUPIN2111.0017.4696528.820.851416.9816.018276.8934.2828.8629.59
8.DRREDDY1154.0029.8996322.060.69435.60-69.108099.80-5.2113.7510.63
9.MANKIND2328.5547.0996179.610.04574.0929.124030.5912.8913.2426.30
10.AUROPHARMA1653.3025.6295127.230.241032.0325.229150.3517.4412.7620.54
11.GLENMARK2427.0038.1068495.930.10482.83927.884018.4831.3520.3520.03
12.AMANTA194.8051.54756.400.003.31-5.6768.805.3515.1621.13
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
686768726571747769
555353535056596265
Operating Profit13141519151515154
OPM %19.68%20.80%22.22%26.31%22.81%20.67%20.62%19.43%5.59%
00101-3121
Interest966665546
Depreciation555555555
Profit before Tax-136852684
Tax %27.45%28.71%22.60%26.87%28.80%46.93%26.67%27.43%26.31%
Net Profit-024641563
-0.130.801.512.111.220.351.351.610.85

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
203211192185184171225259280275291
161160145144147133172208223215242
Operating Profit4151464137385451576049
OPM %20.38%24.27%24.20%22.13%20.27%22.38%23.79%19.64%20.51%21.72%16.77%
212221695110
Interest1412204138404435342820
Depreciation1415161716171718201819
Profit before Tax152512-14-15-1862351521
Tax %16.98%7.59%8.56%-29.34%-24.84%-22.97%12.79%178.46%32.58%28.60%29.10%
Net Profit132311-19-19-2254-241115
EPS0.000.000.000.00-7.04-8.1420.08-0.791.353.64—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
5%
5 Years:
8%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
34%
5 Years:
—
3 Years:
-42%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
—

RETURN ON EQUITY

10 Years:
0%
5 Years:
9%
3 Years:
5%
Last Year:
13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

No bonus data found

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
37372727272727272729
11013440212-2038363968
8676251270277295221220206181
Trade Payables32352922172539362530
1031085963646455555981
Total Liabilities369390406403388392379374355389
246262267247244242241238228217
Capital Work in Progress0120000007
0000023348
30293438395771695973
000000004850
Cash & Bank657136910443
869396104988354601231
Total Assets369390406403388392379374355389

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
43453239382864495847
Cash from Investing-36-21-175-5-11-17-5-7-10-24
Cash from Financing-3-20152-21-35-17-52-42-46-23
0-026-8-06-61-1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
PER SHARE
EPS (₹)3.446.304.26-6.99-7.04-8.1420.08-0.791.353.64
Book Value (₹)40.0246.3224.9817.8810.852.7124.2223.4424.7133.43
Dividend per Share (₹)0.000.000.000.000.000.000.000.000.000.00
Cash EPS (₹)7.1810.2710.43-0.82-0.89-1.7926.526.058.7110.02
PROFITABILITY
Operating Margin %19.97%23.27%25.09%23.04%21.43%23.00%24.16%21.73%20.51%21.72%
Net Margin %5.88%10.30%5.84%-10.14%-10.24%-12.75%23.90%-0.81%1.30%3.82%
ROE %9.33%14.59%9.57%-32.75%-48.98%-120.09%149.18%-3.30%5.63%12.91%
ROCE %10.63%12.69%10.33%8.44%8.27%8.91%39.99%13.43%14.19%15.16%
3.57%6.10%2.85%-4.64%-4.78%-5.60%13.97%-0.56%1.00%2.82%
EFFICIENCY
Debtor Days799210810510311178696665
Inventory Days5748597177103104998488
Payable Days132150171140112157291223159176
4-11-3366856-109-55-9-22
FINANCIAL HEALTH
Debt to Equity (x)0.49x0.40x3.83x5.18x7.94x32.30x3.41x3.43x3.10x2.02x
Interest Coverage (x)2.09x3.04x1.63x0.64x0.60x0.56x2.41x1.08x1.16x1.53x
0.97x1.00x1.18x1.35x1.43x1.06x1.19x1.35x1.15x1.19x
GROWTH
Revenue Growth %15.92%4.15%-9.29%-3.49%-0.27%-7.09%31.61%14.94%8.19%-2.01%
Operating Profit Growth %15.84%21.86%-7.01%-12.42%-7.27%-0.26%38.21%3.40%4.35%3.91%
Net Profit Growth %2198.89%83.30%-51.06%-265.41%-0.69%-15.68%346.78%-103.92%272.14%189.02%
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%272.14%168.97%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x3.88x3.61x

Shareholding Pattern

Numbers in percentages

Dec 2018Sep 2019Mar 2020Mar 2021Mar 2022Sep 2025Dec 2025Mar 2026Jun 2026
92.3592.5292.5292.4092.5963.5663.5663.7263.80
0.000.000.000.000.001.001.100.850.43
0.000.000.000.000.0011.3411.2412.8812.92
Government0.000.000.000.000.000.000.000.000.00
7.657.487.487.607.4124.1024.1022.5622.85

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03
Copy of Newspaper Publication

2026-09-03 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication in respect of special window for transfer and dematerialization requests of physical shares

2026-09-02
General Updates

2026-09-02 - Amanta Healthcare Limited has informed the Exchange about Commissioning of New SteriPort Line

2026-08-25
General Updates

2026-08-25 - Amanta Healthcare Limited has informed the Exchange regarding 'Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations'.

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication for dispatch of Annual Report of the 31st Annual General Meeting ( AGM ) and E-Voting Information

2026-08-24
Shareholders meeting

2026-08-24 - Amanta Healthcare Limited has informed the Exchange about Notice of Annual General Meeting to be held on 16th September, 2026

2026-08-12
Copy of Newspaper Publication

2026-08-12 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication - Advertisement addressed to Shareholders for Annual General Meeting

2026-08-08
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-08 - Amanta Healthcare Limited has informed the Exchange about Transcript

2026-08-08
Monitoring Agency Report

2026-08-08 - Monitoring Agency Report for the quarter ended June 30, 2026

2026-08-07
Copy of Newspaper Publication

2026-08-07 - Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

News

Recent coverage and analyst commentary for AMANTA

Loading news…

🤖

AI Stock Analyst

Amanta Healthcare Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login